{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:58:14Z","timestamp":1780336694099,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66298","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:15:25Z","timestamp":1722964525000},"source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Value of Low-Dose Acetylsalicylic Acid for the Prevention of Preeclampsia in High-Risk Bulgarian Women"],"prefix":"10.7759","author":[{"given":"Boris","family":"Stoilov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Uchikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Kirovakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Zaharieva-Dinkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar R","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013, 33:8-15. 10.1159\/000341264","journal-title":"Fetal Diagn Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.04.018","article-title":"Prediction of preeclampsia utilizing the first trimester screening examination","volume":"211","author":"Baschat AA","year":"2014","unstructured":"Baschat AA, Magder LS, Doyle LE, Atlas RO, Jenkins CB, Blitzer MG. Prediction of preeclampsia utilizing the first trimester screening examination. Am J Obstet Gynecol. 2014, 211:514.e1-7. 10.1016\/j.ajog.2014.04.018","journal-title":"Am J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong P","year":"2022","unstructured":"Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022, 226:S1071-S1097.e2. 10.1016\/j.ajog.2020.07.020","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15021","article-title":"First trimester pre-eclampsia screening: why delay implementation?","volume":"125","author":"Cuckle HS","year":"2018","unstructured":"Cuckle HS. First trimester pre-eclampsia screening: why delay implementation?. BJOG. 2018, 125:450. 10.1111\/1471-0528.15021","journal-title":"BJOG"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman N","year":"2016","unstructured":"O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016, 214:103.e1-103.e12. 10.1016\/j.ajog.2015.08.034","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17317","article-title":"Ophthalmic artery Doppler as a marker of pre-eclampsia: why does it work?","volume":"130","author":"Gonser M","year":"2023","unstructured":"Gonser M, Vonzun L, Ochsenbein-K\u00f6lble N. Ophthalmic artery Doppler as a marker of pre-eclampsia: why does it work?. BJOG. 2023, 130:120-1. 10.1111\/1471-0528.17317","journal-title":"BJOG"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17209","article-title":"Ophthalmic artery Doppler analysis: a window into the cerebrovasculature of women with pre-eclampsia","volume":"49","author":"Kane SC","year":"2017","unstructured":"Kane SC, Brennecke SP, da Silva Costa F. Ophthalmic artery Doppler analysis: a window into the cerebrovasculature of women with pre-eclampsia. Ultrasound Obstet Gynecol. 2017, 49:15-21. 10.1002\/uog.17209","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/uog.23665","article-title":"Ophthalmic artery Doppler in prediction of pre-eclampsia: insights from hemodynamic considerations","volume":"58","author":"Gonser M","year":"2021","unstructured":"Gonser M, Vonzun L, Ochsenbein-K\u00f6lble N. Ophthalmic artery Doppler in prediction of pre-eclampsia: insights from hemodynamic considerations. Ultrasound Obstet Gynecol. 2021, 58:145-7. 10.1002\/uog.23665","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2014.0567","article-title":"Ocular changes during pregnancy","volume":"111","author":"Mackensen F","year":"2014","unstructured":"Mackensen F, Paulus WE, Max R, Ness T. Ocular changes during pregnancy. Dtsch Arztebl Int. 2014, 111:567-76. 10.3238\/arztebl.2014.0567","journal-title":"Dtsch Arztebl Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001480","article-title":"Subfoveal choroidal thickness in pre-eclampsia","volume":"97","author":"Sharudin SN","year":"2020","unstructured":"Sharudin SN, Saaid R, Samsudin A, Mohamad NF. Subfoveal choroidal thickness in pre-eclampsia. Optom Vis Sci. 2020, 97:81-5. 10.1097\/OPX.0000000000001480","journal-title":"Optom Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2012.04.003","article-title":"The eye and visual system in the preeclampsia\/eclampsia syndrome: what to expect?","volume":"27","author":"Abu Samra K","year":"2013","unstructured":"Abu Samra K. The eye and visual system in the preeclampsia\/eclampsia syndrome: what to expect?. Saudi J Ophthalmol. 2013, 27:51-3. 10.1016\/j.sjopt.2012.04.003","journal-title":"Saudi J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13040950","article-title":"Preeclampsia management and maternal ophthalmic artery Doppler measurements between 19 and 23 weeks of gestation","volume":"13","author":"Gyokova E","year":"2024","unstructured":"Gyokova E, Hristova-Atanasova E, Iskrov G. Preeclampsia management and maternal ophthalmic artery Doppler measurements between 19 and 23 weeks of gestation. J Clin Med. 2024, 13:950. 10.3390\/jcm13040950","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis","volume":"347","author":"Ananth CV","year":"2013","unstructured":"Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013, 347:f6564. 10.1136\/bmj.f6564","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie LM","year":"2007","unstructured":"Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007, 369:1791-8. 10.1016\/S0140-6736(07)60712-0","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(03)00169-8","article-title":"Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review","volume":"101","author":"Coomarasamy A","year":"2003","unstructured":"Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol. 2003, 101:1319-32. 10.1016\/s0029-7844(03)00169-8","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah A","year":"2017","unstructured":"Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs. 2017, 77:1819-31. 10.1007\/s40265-017-0823-0","journal-title":"Drugs"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge S","year":"2017","unstructured":"Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017, 216:110-120.e6. 10.1016\/j.ajog.2016.09.076","journal-title":"Am J Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold E","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, et al.. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010, 116:402-14. 10.1097\/AOG.0b013e3181e9322a","journal-title":"Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik DL","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022, 226:S1108-19. 10.1016\/j.ajog.2020.08.045","journal-title":"Am J Obstet Gynecol"},{"key":"ref20","unstructured":"Bulgarian association of obstetrics and gynecology (Website in Bulgarian). (2011). Accessed. July 16, 2024: https:\/\/bsobgyn.com\/guidelines\/akusherstvo\/10.%20%D0%9F%D1%80%D0%B5%D0%B5%D0%BA%D0%BB%D0%B0%D0%BC%D0%BF%D1%81%D0%B8%D...."},{"key":"ref21","unstructured":"Placental dysfunction - screening model for risk assessment. (2016). Accessed. July, 2024: https:\/\/eprints.mu-varna.bg\/handle\/nls\/363."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai BM","year":"1993","unstructured":"Sibai BM, Caritis SN, Thom E, et al.. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993, 329:1213-8. 10.1056\/NEJM199310213291701","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19116","article-title":"Quality assessment of uterine artery Doppler measurement in first-trimester combined screening for pre-eclampsia","volume":"53","author":"Rolnik DL","year":"2019","unstructured":"Rolnik DL, da Silva Costa F, Sahota D, Hyett J, McLennan A. Quality assessment of uterine artery Doppler measurement in first-trimester combined screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2019, 53:245-50. 10.1002\/uog.19116","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O'Gorman N","year":"2017","unstructured":"O'Gorman N, Wright D, Poon LC, et al.. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017, 49:756-60. 10.1002\/uog.17455","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan MY","year":"2018","unstructured":"Tan MY, Wright D, Syngelaki A, et al.. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018, 51:743-50. 10.1002\/uog.19039","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright D","year":"2019","unstructured":"Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019, 220:199.e1-199.e13. 10.1016\/j.ajog.2018.11.1087","journal-title":"Am J Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright D","year":"2015","unstructured":"Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015, 213:62.e1-62.e10. 10.1016\/j.ajog.2015.02.018","journal-title":"Am J Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright D","year":"2017","unstructured":"Wright D, Poon LC, Rolnik DL, et al.. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017, 217:685.e1-5. 10.1016\/j.ajog.2017.08.110","journal-title":"Am J Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/21642850.2021.1951273","article-title":"Aspirin non-adherence in pregnant women at risk of preeclampsia (ANA): a qualitative study","volume":"9","author":"Vinogradov R","year":"2021","unstructured":"Vinogradov R, Smith VJ, Robson SC, Araujo-Soares V. Aspirin non-adherence in pregnant women at risk of preeclampsia (ANA): a qualitative study. Health Psychol Behav Med. 2021, 9:681-700. 10.1080\/21642850.2021.1951273","journal-title":"Health Psychol Behav Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11070989","article-title":"Preconception-health-related attitudes of Bulgarian women of reproductive age","volume":"11","author":"Hristova-Atanasova E","year":"2023","unstructured":"Hristova-Atanasova E, Iskrov G, Raycheva R, Mandova V, Stefanov R. Preconception-health-related attitudes of Bulgarian women of reproductive age. Healthcare (Basel). 2023, 11:989. 10.3390\/healthcare11070989","journal-title":"Healthcare (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255739-therapeutic-value-of-low-dose-acetylsalicylic-acid-for-the-prevention-of-preeclampsia-in-high-risk-bulgarian-women","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:15:29Z","timestamp":1722964529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255739-therapeutic-value-of-low-dose-acetylsalicylic-acid-for-the-prevention-of-preeclampsia-in-high-risk-bulgarian-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.66298","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}